New Antitubercular Drugs Designed by Molecular Modification

doi 10.5772/33169
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech

Related search

Tuberculosis After Gastrectomy, Plasmatic Concentration of Antitubercular Drugs

Mediterranean Journal of Hematology and Infectious Diseases
Infectious DiseasesHematology
2012English

New Molecular Imaging With Precisely Designed Smart Fluorescence Probes

Drug Delivery System
Pharmaceutical Science
2011English

Inhibitors of Type II NADH:menaquinone Oxidoreductase Represent a Class of Antitubercular Drugs

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2005English

Development of a Novel Screening Strategy Designed to Discover a New Class of HIV Drugs

Journal of laboratory automation
Computer Science ApplicationsMedicineMedical Laboratory Technology
2013English

Modification of Insulin and Sulfonylurea Hypoglycemia by Monoamine-Oxidase Inhibitor Drugs

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
1967English

Modification by Drugs of Urinary Fibrin Fibrinogen Degradation Products in Glomerulonephritis

BMJ
1972English

Synthesis, Antibacterial, Antifungal Antitubercular Activities and Molecular Docking Studies of Nitrophenyl Derivatives

International Journal of Pharma and Bio Sciences
BiochemistryBiotechnologyCell BiologyMolecular Biology
2019English

Modification of Cardiovascular Risk: Lifestyle v. Drugs

Proceedings of the Nutrition Society
MedicineNutritionDietetics
2000English

In Vitro Interactions Between New Antitubercular Drug Candidates SQ109 and TMC207

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy